Bioavailability of two clodronate formulations.

Br J Hosp Med

Boehringer Ingelheim Limited, Bracknell, Berkshire.

Published: January 1997

Sodium clodronate is effective in the management of osteolytic lesions, hypercalcaemia and bone pain associated with skeletal metastasis. Clinical and biochemical data underpin a licensed total daily dose of 1600-3200 mg.

Download full-text PDF

Source

Publication Analysis

Top Keywords

bioavailability clodronate
4
clodronate formulations
4
formulations sodium
4
sodium clodronate
4
clodronate effective
4
effective management
4
management osteolytic
4
osteolytic lesions
4
lesions hypercalcaemia
4
hypercalcaemia bone
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!